168 related articles for article (PubMed ID: 17977581)
1. Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding.
Belizna CC; Richard V; Primard E; Kerleau JM; Cailleux N; Louvel JP; Marie I; Hamidou M; Thuillez C; Lévesque H
Semin Arthritis Rheum; 2008 Jun; 37(6):373-80. PubMed ID: 17977581
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
3. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
4. [Traditional risk factors for cardiovascular disease in primary antiphospholipid syndrome (APS) when compared with secondary APS: a study with 96 patients].
Ribeiro AR; Carvalho JF
Acta Reumatol Port; 2010; 35(1):36-41. PubMed ID: 20505627
[TBL] [Abstract][Full Text] [Related]
5. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
7. Cardiac manifestations in antiphospholipid syndrome.
Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
[TBL] [Abstract][Full Text] [Related]
8. Peripheral vascular disease in antiphospholipid syndrome.
Vlachoyiannopoulos PG; Samarkos M
Thromb Res; 2004; 114(5-6):509-19. PubMed ID: 15507285
[TBL] [Abstract][Full Text] [Related]
9. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.
Shang Q; Tam LS; Li EK; Yip GW; Yu CM
Lupus; 2008 Dec; 17(12):1096-102. PubMed ID: 19029277
[TBL] [Abstract][Full Text] [Related]
10. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
Mathieu S; Joly H; Baron G; Tournadre A; Dubost JJ; Ristori JM; Lusson JR; Soubrier M
Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
[TBL] [Abstract][Full Text] [Related]
11. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
12. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
Zanchetti A; Hennig M; Hollweck R; Bond G; Tang R; Cuspidi C; Parati G; Facchetti R; Mancia G
Circulation; 2009 Sep; 120(12):1084-90. PubMed ID: 19738145
[TBL] [Abstract][Full Text] [Related]
13. Influence of haemodialysis on early markers of atherosclerosis.
Kovacic V; Ljutic D; Dodig J; Radic M; Duplancic D
Nephrology (Carlton); 2008 Dec; 13(6):472-9. PubMed ID: 18518941
[TBL] [Abstract][Full Text] [Related]
14. Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.
Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
Semin Arthritis Rheum; 2018 Jun; 47(6):883-889. PubMed ID: 29150207
[TBL] [Abstract][Full Text] [Related]
15. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction.
Vlachopoulos C; Aznaouridis K; Ioakeimidis N; Rokkas K; Tsekoura D; Vasiliadou C; Stefanadi E; Askitis A; Stefanadis C
J Hypertens; 2008 Sep; 26(9):1829-36. PubMed ID: 18698219
[TBL] [Abstract][Full Text] [Related]
16. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study.
Juonala M; Viikari JS; Rönnemaa T; Marniemi J; Jula A; Loo BM; Raitakari OT
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):1012-7. PubMed ID: 18309111
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
Pengo V; Bison E; Ruffatti A; Iliceto S
Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.
Ames PR; Margarita A; Alves JD
Clin Rev Allergy Immunol; 2009 Aug; 37(1):29-35. PubMed ID: 18987784
[TBL] [Abstract][Full Text] [Related]
19. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
[TBL] [Abstract][Full Text] [Related]
20. [Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome].
Aleksandrova EN; Novikov AA; Popkova TV; Reshetniak TM; Novikova DS; Kliukvina NG; Il'ina AE; Mach ES; Volkov AV; Nasonov EL
Ter Arkh; 2006; 78(6):35-9. PubMed ID: 16881361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
